An editor has nominated this article for deletion. You are welcome to participate in the deletion discussion, which will decide whether to keep it. |
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Profhilo is a brand of hyaluronic-acid based injectable products developed by IBSA Derma, a division of the Swiss pharmaceutical company IBSA.[1] Introduced in 2015, the brand has been described in medical, industry and media sources for its formulation using IBSA’s NAHYCO technology and its registration as a CE-marked device.[2][3] The brand name has also been associated with a set of related products, including Profhilo Body, Haenkenium cream and Profhilo Structura, as well as clinical protocols such as the BAP technique.[4][5] The brand is distributed in different countries through local partners and importers listed in regional markets.[6]
| Country | Switzerland |
|---|---|
| Introduced | 2015 |
| Markets | Europe, Asia, Middle East and other regions |
| Website | https://www.profhilo.co.uk/ |
Research published in clinical journals has examined its safety profile and application in areas such as facial and neck skin, reporting low rates of adverse reactions and discussing potential benefits in certain cases.[7][8]
See also
editReferences
edit- ^ "Profhilo: IBSA Derma". Retrieved 19 November 2025.
- ^ "Profhilo: Skin remodelling treatment". Retrieved 19 November 2025.
- ^ "Hybrid Cooperative Complexes of Hyaluronic Acid: A New Concept in Skin Remodelling". Journal of Aesthetic Medicine. 2018.
- ^ "BAP Protocol for Profhilo". Retrieved 19 November 2025.
- ^ "Profhilo Structura". Retrieved 19 November 2025.
- ^ "Paeezan Tejarat Mehr – IBSA Derma Distributor Information". Retrieved 19 November 2025.
- ^ "Safety of Hybrid Cooperative Complex Hyaluronic Acid". BioMed Research International. 2020.
- ^ "Hybrid Hyaluronic Acid Complex for Treatment of Neck Skin Laxity". The Scientific World Journal. 2022.